10.1002/cplu.201800541
ChemPlusChem
FULL PAPER
3.15 (6 H, m, -CH2-O-, -CH2-S-); 3.20-3.61 (6 H, m, -CH2-O-, -CH-OH);
4.32 (1 H, br s, -NH-); 4.94-4.99 (2 H, m, -OH); 6.44-6.53 (1 H, m, -ArH);
6.56-6.67 (1 H, m, -ArH); 6.69-7.10 (1 H, m, -ArH); 7.20-7.30 (1 H, m, -
ArH). 13C NMR (DMSO-d6, 100 MHz): (δ, ppm) 22.11, 22.53, 36.36, 37.07,
38.84, 67.53, 68.68, 74.13, 74.51, 77.25, 77.37, 79.61, 110.38, 114.71,
116.98, 129.40, 135.06, 135.26, 149.14, 149.64 (SI Figure S7). HRMS
(ESI-TOF), m/z calculated for C17H27NSO4Na+: 364.1558 [M+Na]+; found:
364.1548 (SI Figure S8).
reaction conditions afforded 3.45 g (93%) 2h, a viscous clear liquid purified
using column chromatography SiO2 eluted by 1:20 (MeOH:CHCl3) Rf=0.79.
IR (ATR) vmax/cm-1: 3561, 3060, 2980, 2920, 2879, 1606, 1477, 1448, 1366,
1304, 1248, 1220, 1145, 1071, 1030, 934, 848, 809, 748, 665, 591. 1H
NMR (DMSO-d6, 400 MHz): (δ, ppm) 1.01-1.07 (12 H, m, –CH3); 2.81-3.07
(4 H, m, -CH2-S-); 3.11-3.61 (6 H, m, -CH2-O-, -CH-OH); 4.91-4.96 (2 H,
m, -OH); 7.06-7.21 (2 H, m, -ArH); 7.35-7.46 (2 H, m, -ArH). 13C NMR
(DMSO-d6, 100 MHz): (δ, ppm) 19.67, 20.34, 21.72, 23.41, 36.81, 38.34,
64.25, 66.34, 67.00, 68.61, 69.33, 70.18, 79.19, 79.61, 80.58, 124.06,
126.91, 127.41, 127.55, 129.68, 129.88, 131.94, 132.27, 134.49, 134.61,
136.96, 137.80 (SI Figure S11). HRMS (ESI-TOF), m/z calculated for
C18H28S2O4Na+: 395.1327 [M+Na]+; found: 395.1314 (SI Figure S12).
Synthesis of 2i: 6,7,8,15,16,17-hexahydrodibenzo [1,4,8,11] dioxa-
dithiacyclotetra decine-7,16-diol. Reaction of 1.42 g (10 mmol) c with 2.22
g (10 mmol) 1c using optimized catalyst/template reaction conditions
afforded 3.27 g (90%) 2i, a glassy clear solid purified using column
chromatography SiO2 eluted by 1:20 (MeOH:CHCl3) Rf=0.65. IR (KBr)
vmax/cm-1: 3619, 3342, 3058, 3007, 2932,2870, 1587, 1499, 1450, 1313,
1252, 1213, 1116, 1073, 1030, 931, 836, 742, 665, 652, 592. 1H NMR
(DMSO-d6, 400 MHz): (δ, ppm) 2.97-3.07 (2 H, m, –CH2-S-), 3.18-3.21 (2
H, m, –CH2-S-), 3.96 (6 H, b, –CH2-O-, -CH-OH), 5.33-5.36 (2 H, m, -OH),
6.82-6.84 (2 H, m, -ArH), 6.91-6.92 (2 H, m, -ArH), 7.04-7.11 (2 H, m, -
ArH), 7.27-7.33 (2 H, m, -ArH). 13C NMR (DMSO-d6, 100 MHz): (δ, ppm)
38.66, 49.05, 68.11, 72.11, 79.61, 114.73, 121.73, 126.37, 127.93, 136.39,
148.82 (SI Figure S13). HRMS (ESI-TOF), m/z calculated for
C18H20S2O4Na+: 387.0701 [M+Na]+; found: 387.0692 (SI Figure S14).
Synthesis of 2e: 6,6,7,7-tetramethyl-3,4,6,7,9,10, 11,12-octahydro-2H
benzo [1,4,8,11] dioxathiaaza cyclotetra-decine-3,10-diol. Reaction of 1.25
g (10 mmol) b with 2.30 g (10 mmol) 1b using optimized catalyst/template
reaction conditions afforded 2.23 g (63%) 2e, a viscous yellow liquid
purified using column chromatography SiO2-Al2O3 (acidic) (10:1 v/v) eluted
by 1:15 (MeOH:CHCl3) Rf=0.42. IR (ATR) vmax/cm-1: 3525, 3396, 3052,
2982, 2922, 2871, 1567, 1442, 1367, 1219, 1146, 1069, 1030, 932, 854,
749, 662, 598. 1H NMR (DMSO-d6, 400 MHz): (δ, ppm) 0.96-1.06 (6 H, m,
2 –CH3); 2.61-2.67 (2 H, m, -CH2-NH-); 2.83-2.89 (2 H, m, -CH2-S-); 3.21-
3.43 (4 H, m, -CH2-O-); 3.49-3.69 (2 H, m, -CH-OH); 4.61 (1 H, br s, -NH-);
5.11 (2 H, m, -OH); 6.44-6.46 (1 H, m, -ArH); 6.65-6.67 (1 H, m, -ArH);
6.94-6.98 (1 H, m, -ArH); 7.19-7.22 (1 H, m, -ArH). 13C NMR (DMSO-d6,
100 MHz): (δ, ppm) 20.27, 20.33, 39.03, 64.89, 69.51, 79.07, 79.61,
114.89, 116.85, 117.14, 129.33, 134.92, 149.58. HRMS (ESI-TOF), m/z
calculated for C18H29NSO4Na+: 378.1715 [M+Na]+; found: 378.1693.
Synthesis of 2f: 7,8,14,15,16,17-hexahydro-6H-dibenzo [1,4,8,11]
dioxathiaaza cyclotetradecine-7,16-diol. Reaction of 1.25 g (10 mmol) b
with 2.22 g (10 mmol) 1c using optimized catalyst/template reaction
conditions afforded 2.01 g (58%) 2f, a yellow solid purified using column
chromatography SiO2-Al2O3 (acidic) (10:1 v/v) eluted by 1:15
(MeOH:CHCl3) Rf=0.29. IR (KBr) vmax/cm-1: 3618, 3394, 3055, 3001, 2922,
2871, 1590, 1501, 1447, 1328, 1252, 1215, 1116, 1073, 1026, 917, 835,
742, 662, 596. 1H NMR (DMSO-d6, 400 MHz): (δ, ppm) 2.72-2.95 (2 H, m,
-CH2-NH-); 2.97-3.42 (2 H, m, -CH2-S-); 3.62-4.02 (4 H, m, -CH2-O-, -CH-
OH); 4.60-4.63 (1 H, m, -NH-); 5.11-5.21 (2 H, m, -OH); 6.50-6.53 (1 H, m,
-ArH); 6.66-6.70 (1 H, m, -ArH); 6.81-7.16 (5 H, m, -ArH); 7.17-7.36 (1 H,
m, -ArH). 13C NMR (DMSO-d6, 100 MHz): (δ, ppm) 38.17, 38.66, 46.63,
51.61, 68.06, 68.35, 70.48, 71.27, 72.27, 79.62, 114.57, 115.47, 116.65,
116.94, 117.34, 119.10, 121.77, 127.52, 129.49, 129.97, 131.70, 135.11,
148.97. HRMS (ESI-TOF), m/z calculated for C18H21NSO4Na+: 370.1089
[M+Na]+; found: 370.1079.
Liquid-liquid extraction procedure
All vessels used were acid-washed in 5% HNO3 for 24 h followed by
intensive washing with DI water. Before experiments, CHCl3 was
equilibrated with DI water to ensure constant extractant phase volume
before and after LLE. Simulated Pd and Pt solutions or multi-component
ICP standard solutions were diluted in 2M HCl as the aqueous phase. For
the LLE experiments, Pt or Pd solutions with volume Vaq were contacted
with the CE-containing extractants with volume Vorg at Vaq/Vorg = 1 ratio.
Metal analyses were performed using 1 mL aqueous samples collected
before (Ci) and after (Cf at equilibrium) LLE. The samples were digested
using MARS-5 microwave unit (CEM, USA) and analyzed using inductively
coupled plasma – mass spectrometry (ICP-MS Agilent 7500 series, USA).
Extraction results were calculated using Eqs. (1) and (2) as metal
distribution coefficients (DMn+) and metal selectivity (β), respectively.
Synthesis of 2g: 7,7-dimethyl-3,4,6,7,8,10,11,12-octahydro-2H-benzo
[1,5,9,12] dioxadithiacyclopentadecine-3,11-diol. Reaction of 1.42 g (10
mmol) c with 2.16 g (10 mmol) 1a using optimized catalyst/template
reaction conditions afforded 3.08 g (86%) 2g, a viscous clear liquid purified
using column chromatography SiO2 eluted by 1:20 (MeOH:CHCl3) Rf=0.76.
IR (ATR) vmax/cm-1: 3523, 3057, 2954, 2867, 1588, 1502, 1478, 1450, 1359,
1309, 1283, 1220, 1105, 1042, 748, 648,663, 579. 1H NMR (DMSO-d6,
400 MHz): (δ, ppm) 0.67-0.72 (6 H, m, –CH3); 2.86-3.11 (8 H, m, –CH2-S-,
-CH2-O-), 3.22-3.34 (6 H, m, –CH2-O-), 3.71-3.75 (2 H, m, -CH-OH), 5.02
(2 H, br s, -OH), 7.14-7.20 (2 H, m, -ArH), 7.38-7.45 (2 H, m, -ArH). 13C
NMR (DMSO-d6, 100 MHz): (δ, ppm) 22.44, 22.47, 36.20, 37.01, 37.82,
67.66, 68.96, 73.94, 74.28, 75.27, 75.38, 79.61, 127.38, 127.44, 131.06,
131.25, 137.36, 137.86 (SI Figure S9). HRMS (ESI-TOF), m/z calculated
for C17H26S2O4Na+: 381.1170 [M+Na]+; found: 381.1162 (SI Figure S10).
Synthesis of 2h: 6,6,7,7-tetramethyl-2,3,4,6,7,9,10,11-octahydro-
benzo[i] [1,4,8,11] dioxadithiacyclotetradecine-3,10-diol. Reaction of 1.42
g (10 mmol) c with 2.30 g (10 mmol) 1b using optimized catalyst/template
Eq. (1)
Eq. (2)
Ci Cf Vaq
DM n
Cf
Vorg
D
2
2
Pd _or_ Pt
( Pd 2
_or_ Pt 2 )/ M n
D
n
M
Quantum chemical calculation details
All calculations were performed using Schrodinger Materials Science Suite
version 2015-4 with Jaguar ab initio electronic structure program
This article is protected by copyright. All rights reserved.